Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al
- Gia thanh cha thc s tip cn vi moi nhom khach hang, c bit la hoc sinh, sinh vin
Contact us today for more information, or schedule an appointment online
aureus MRSA and MSSA (=10 g/ml)
Side Effects & Safety Injection site reactions mild redness or swelling, resolves quickly (documented in clinical-era adverse-event reports) Flushing brief facial warmth Dizziness mild and transient (uncommon) Headache uncommon, typically mild Favorable safety profile Sermorelin's clinical-era trial record documented a favorable adverse-event profile across its years of approved diagnostic use (Prakash & Bhatt, 2020) No significant drug interactions identified during clinical era Documented exclusion criteria: Clinical protocols documented exclusion criteria including active malignancy (on theoretical concern about growth-promoting effects), pregnancy or breastfeeding, and severe renal or hepatic impairment